244
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Quality of Life and Limitations in Daily Life of Stable COPD Outpatients in a Real-World Setting in Austria – Results from the CLARA Project

ORCID Icon, , , , , ORCID Icon, , ORCID Icon & show all
Pages 1655-1663 | Published online: 12 Jul 2020

References

  • SinghD, AgustiA, AnzuetoA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-201930846476
  • GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Respir Med. 2017;5(9):691–706. doi:10.1016/S2213-2600(17)30293-X28822787
  • WangH, NaghaviM, AllenC. Mortality, causes of death c. global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459–1544. doi:10.1016/S0140-6736(16)31012-127733281
  • MiniatiM, MontiS, PavlickovaI, BottaiM. Survival in COPD: impact of lung dysfunction and comorbidities. Medicine. 2014;93(12):e76. doi:10.1097/MD.000000000000007625211048
  • VasankariTM, ImpivaaraO, HeliovaaraM, et al. No increase in the prevalence of COPD in two decades. Eur Respir J. 2010;36(4):766–773. doi:10.1183/09031936.0017810920693258
  • BerryCE, WiseRA. Mortality in COPD: causes, risk factors, and prevention. Copd. 2010;7(5):375–382. doi:10.3109/15412555.2010.51016020854053
  • JonesPW, QuirkFH, BaveystockCM, LittlejohnsP. A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992;145(6):1321–1327. doi:10.1164/ajrccm/145.6.13211595997
  • JonesPW, QuirkFH, BaveystockCM. The St George’s Respiratory Questionnaire. Respir Med. 1991;85(Suppl B):25–31. doi:10.1016/S0954-6111(06)80166-61759018
  • MeguroM, BarleyEA, SpencerS, JonesPW. Development and validation of an improved, COPD-specific version of the St. George Respiratory Questionnaire. Chest. 2007;132(2):456–463. doi:10.1378/chest.06-070217646240
  • AhmedMS, NeyazA, AslamiAN. Health-related quality of life of chronic obstructive pulmonary disease patients: results from a community based cross-sectional study in Aligarh, Uttar Pradesh, India. Lung India. 2016;33(2):148–153. doi:10.4103/0970-2113.17743827051101
  • RingbaekT, MartinezG, LangeP. A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation. Copd. 2012;9(1):12–15. doi:10.3109/15412555.2011.63024822292593
  • HumenbergerM, HornerA, LabekA, et al. Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD). BMC Pulm Med. 2018;18(1):163. doi:10.1186/s12890-018-0724-330340565
  • PaapMC, LangeL, van der PalenJ, BodeC. Using the three-step test interview to understand how patients perceive the St. George’s Respiratory Questionnaire for COPD patients (SGRQ-C). Quality Life Res. 2016;25(6):1561–1570. doi:10.1007/s11136-015-1192-3
  • St George’s Respiratory Questionaire for COPD Patients (SGRQ-C) Manual; Available from: http://www.healthstatus.sgul.ac.uk/SGRQ_download/sgrq-c-manual-april-2012.pdf accessed 121 2020.
  • CleutjensF, SpruitMA, PondsR, et al. Cognitive impairment and clinical characteristics in patients with chronic obstructive pulmonary disease. Chron Respir Dis. 2018;15(2):91–102. doi:10.1177/147997231770965128553720
  • BraekenDCW, SpruitMA, Houben-WilkeS, et al. Impact of exacerbations on adherence and outcomes of pulmonary rehabilitation in patients with COPD. Respirology. 2017;22(5):942–949. doi:10.1111/resp.1298728139873
  • ChaiCS, LiamCK, PangYK, et al. Clinical phenotypes of COPD and health-related quality of life: a cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2019;14:565–573. doi:10.2147/COPD.S19610930880946
  • LeeH, JhunBW, ChoJ, et al. Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity. Int J Chron Obstruct Pulmon Dis. 2017;12:3301–3310. doi:10.2147/COPD.S14591029180860
  • MerinoM, VilloroR, ÁH-V, CarmonaC. Health-related quality of life of patients diagnosed with COPD in Extremadura, Spain: results from an observational study. Health Qual Life Outcomes. 2019;17(1):189. doi:10.1186/s12955-019-1244-431888646
  • JonesPW, BrusselleG, Dal NegroRW, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med. 2011;105(1):57–66. doi:10.1016/j.rmed.2010.09.00420932736
  • WackerME, JörresRA, KarchA, et al. Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulm Med. 2016;16(1):70. doi:10.1186/s12890-016-0238-927160582
  • MihaltanF, AdirY, AntczakA, et al. Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study. Respir Res. 2019;20(1):89. doi:10.1186/s12931-019-1053-731088560
  • AndrianopoulosV, WoutersEF, Pinto-PlataVM, et al. Prognostic value of variables derived from the six-minute walk test in patients with COPD: results from the ECLIPSE study. Respir Med. 2015;109(9):1138–1146. doi:10.1016/j.rmed.2015.06.01326143282
  • MapelDW, DalalAA, JohnsonP, BeckerL, HunterAG. A clinical study of COPD severity assessment by primary care physicians and their patients compared with spirometry. Am J Med. 2015;128(6):629–637. doi:10.1016/j.amjmed.2014.12.01825595469
  • BurchetteJE, ClickIA, JohnsonL, WilliamsSA, MorganBT. Relationship of patient self-administered COPD assessment test to physician standard assessment of chronic obstructive pulmonary disease in a family medicine residency training program. J Patient Centered Res Rev. 2019;6(3):210–215. doi:10.17294/2330-0698.1699
  • HartlS, Lopez-CamposJL, Pozo-RodriguezF, et al. Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD audit. Eur Respir J. 2016;47(1):113–121. doi:10.1183/13993003.01391-201426493806
  • MullerovaH, MaselliDJ, LocantoreN, et al. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest. 2015;147(4):999–1007. doi:10.1378/chest.14-065525356881
  • AlcazarB, Garcia-PoloC, HerrejonA, et al. Factors associated with hospital admission for exacerbation of chronic obstructive pulmonary disease. Arch Bronconeumol. 2012;48(3):70–76. doi:10.1016/j.arbres.2011.10.00922196478
  • LamprechtB, SorianoJB, StudnickaM, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148(4):971–985. doi:10.1378/chest.14-253525950276
  • SatorL, HornerA, StudnickaM, et al. Overdiagnosis of COPD in subjects with unobstructed spirometry: a BOLD analysis. Chest. 2019;156(2):277–288. doi:10.1016/j.chest.2019.01.01530711480